Our objectives were to quantitate insulin-stimulated inward glucose transport and glucose phosphorylation in forearm muscle in lean and obese nondiabetic subjects, in lean and obese type 2 diabetic (T2DM) subjects, and in normal glucose-tolerant, insulin-resistant offspring of two T2DM parents. Subjects received a euglycemic insulin (40 mU ⅐ m Ϫ2 ⅐ min Ϫ1 ) clamp with brachial artery/deep forearm vein catheterization. After 120 min of hyperinsulinemia, a bolus of3 H]glucose (tripletracer technique) was given into brachial artery and deep vein samples obtained every 12-30 s for 15 min. Insulin-stimulated forearm glucose uptake (FGU) and whole body glucose metabolism (M) were reduced by 40 -50% in obese nondiabetic, lean T2DM, and obese T2DM subjects (all P Ͻ 0.01); in offspring, the reduction in FGU and M was ϳ30% (P Ͻ 0.05). Inward glucose transport and glucose phosphorylation were decreased by ϳ40 -50% (P Ͻ 0.01) in obese nondiabetic and T2DM groups and closely paralleled the decrease in FGU. The intracellular glucose concentration in the space accessible to glucose was significantly greater in obese nondiabetic, lean T2DM, obese T2DM, and offspring compared with lean controls. We conclude that 1) obese nondiabetic, lean T2DM, and offspring manifest moderate-tosevere muscle insulin resistance (FGU and M) and decreased insulin-stimulated glucose transport and glucose phosphorylation in forearm muscle; these defects in insulin action are not further reduced by the combination of obesity plus T2DM; and 2) the increase in intracelullar glucose concentration under hyperinsulinemic euglycemic conditions in obese and T2DM groups suggests that the defect in glucose phosphorylation exceeds the defect in glucose transport. insulin resistance; muscle; glucose phosphorylation; type 2 diabetes; obesity INSULIN RESISTANCE IN MUSCLE, the primary tissue responsible for glucose disposal (18), is a characteristic feature of type 2 diabetes mellitus (T2DM) (19,20,31) and obesity (4,5,19,20,31,33). In T2DM, impaired insulin action is an inherited trait (41, 65), whereas in obesity insulin resistance is acquired (58) secondarily to disturbances in free fatty acid (FFA) metabolism (27, 53), altered fat topography (13), and deranged secretion of adipocytokines (3). Skeletal muscle insulin resistance in T2DM and obesity affects both the glycogen synthetic and glucose oxidative pathways (22), suggesting a proximal defect in insulin action. Recent studies have demonstrated multiple disturbances in insulin signaling in T2DM subjects (15,35,36). However, there has been considerable debate about the contributions of impaired glucose transport vs. reduced glucose phosphorylation to the defect in insulin action in T2DM (6, 7, 12, 36, 56, 66 -68).Only one previous study (7) has examined the contributions of impaired muscle glucose transport vs. reduced glucose phosphorylation to the defect in insulin action in lean T2DM subjects. Inward transmembrane glucose transport was markedly impaired in lean T2DM subjects under conditions of euglycemic...